Short sellers circle IperionX after typo blunder as Spruce Point hints at second attack
The dual-listed critical minerals company is drawing fresh short interest after a major accounting correction wiped more than a fifth off its share price on Tuesday.
A US short seller which published a scathing report on ASX-listed IperionX late last year may be gearing up for a second swing at the critical minerals company after an accounting correction spooked shareholders on Monday.
New York-based Spruce Point Capital Management — whose short report in November warned investors that IperionX could be “significantly overvalued” — suggested the “typographical error” may warrant a “closer look” at the company.
“IperionX, a company promoting its ability to ‘revolutionize’ the titanium industry pooh-poohed our concerns about its PP&E and internal control issues in our forensic report from Nov 2025,” Spruce Point founder and chief investment officer Ben Axler wrote in a LinkedIn post.
“While reporting increased losses and providing no real update about press releases claiming ‘prototype’ ‘orders’, IPX issues a massive correction for an error in their PP&E.
